Reagent Kit for Quantitative Determination of Cancer Antigen CA-62 in Human Serum by Immunochemiluminescent Assay (ICLA-CA-62) Reagent Kit for Quantitative Determination of Cancer Antigen CA-62 in Human Serum by Immunochemiluminescent Assay (ICLA-CA-62) For in vitro diagnostic use according to TU 21.20.23-001-17673329-2018 Kit Composition I. Reagent Kit with Accessories 96-well polystyrene microplate, black, strip format, pre-coated with immobilized mouse monoclonal IgM antibodies to cancer antigen CA-62, ready to use – 1 pc. Conjugate "CA-62-Acridine" labeled with luminescent acridine, requires dilution as specified in the device passport – 0.1 ml (1 vial). Standard CA-62 calibrators based on human serum with known CA-62 concentrations: 50, 250, 650, 1250, 2500, 5000, 7000, and 10000 U/ml, ready to use – 0.5 ml (8 vials). Positive control sample based on human serum with a known CA-62 concentration (7000–10000 U/ml), ready to use – 1 ml (1 vial). Working buffer solution with Tween-80, ready to use – 25 ml (1 vial). Working solution A for Chemiluminometer Dispenser 1, ready to use – 25 ml (1 vial). Working solution B for Chemiluminometer Dispenser 2, ready to use – 25 ml (1 vial). II. Documentation User manual – 1 pc. Device passport – 1 pc. Intended Use The reagent kit is intended for the quantitative determination of cancer antigen CA-62 in human serum by immunochemiluminescent assay (ICLA). It provides reliable and accurate results for in vitro diagnostics, assisting in clinical decision-making and disease monitoring. If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Quantitative Determination of Cancer Antigen CA-62 in Human Serum by Immunochemiluminescent Assay (ICLA-CA-62), then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM. The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only. Старая цена: 0.00 EUR Back Copyright MAXXmarketing GmbHJoomShopping Download & Support
Reagent Kit for Quantitative Determination of Cancer Antigen CA-62 in Human Serum by Immunochemiluminescent Assay (ICLA-CA-62) For in vitro diagnostic use according to TU 21.20.23-001-17673329-2018 Kit Composition I. Reagent Kit with Accessories 96-well polystyrene microplate, black, strip format, pre-coated with immobilized mouse monoclonal IgM antibodies to cancer antigen CA-62, ready to use – 1 pc. Conjugate "CA-62-Acridine" labeled with luminescent acridine, requires dilution as specified in the device passport – 0.1 ml (1 vial). Standard CA-62 calibrators based on human serum with known CA-62 concentrations: 50, 250, 650, 1250, 2500, 5000, 7000, and 10000 U/ml, ready to use – 0.5 ml (8 vials). Positive control sample based on human serum with a known CA-62 concentration (7000–10000 U/ml), ready to use – 1 ml (1 vial). Working buffer solution with Tween-80, ready to use – 25 ml (1 vial). Working solution A for Chemiluminometer Dispenser 1, ready to use – 25 ml (1 vial). Working solution B for Chemiluminometer Dispenser 2, ready to use – 25 ml (1 vial). II. Documentation User manual – 1 pc. Device passport – 1 pc. Intended Use The reagent kit is intended for the quantitative determination of cancer antigen CA-62 in human serum by immunochemiluminescent assay (ICLA). It provides reliable and accurate results for in vitro diagnostics, assisting in clinical decision-making and disease monitoring.
